1-20 of 152
Jian Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Teclistamab induced rapid and deep hematologic response in relapsed/refractory light chain amyloidosis: A multicenter retrospective study

Free
Kaini Shen, Liye Zhong, Peilong Lai, Chunyan Sun, Donghua He, Ai Guan, Yi Xu, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 7492.
https://doi.org/10.1182/blood-2025-7492
Published: 2025
Journal Articles

Golidocitinib combined with CHOP in newly-diagnosed peripheral T-cell lymphoma: Preliminary Results from A phase 1/2 clinical trial

Free
Chong Wei, Wei Zhang, Dao-Bin Zhou, Jian Li, Yan Zhang, Kaini Shen, Wei Wang, Zi Wang, Danqing Zhao, Jing Ruan, Huacong Cai, Yueying Mao
Journal: Blood
Blood (2025) 146 (Supplement 1): 6322.
https://doi.org/10.1182/blood-2025-6322
Published: 2025
Journal Articles

FLAG-IDA as frontline induction improves outcomes in pediatric patients with core-binding factor or KMT2A-rearranged acute myeloid leukemia: A multicenter cohort study in southern China

Free
Yongzhi Zheng, Jian Li, Huiping Li, Mincui Zheng, Benshan Zhang, Huirong Mai, Sixi Liu, Changgang Li, Lihua Yang, L Yu, Hua Jiang, Yingyi He, Xiangling He, Keke Chen, Hong Wen, Honggui Xu, Nainong Li, Zhiyong Peng, Chunfu Li, Xiaoqin Feng
Journal: Blood
Blood (2025) 146 (Supplement 1): 5152.
https://doi.org/10.1182/blood-2025-5152
Published: 2025
Journal Articles

Deciphering the bone marrow inflammatory cytokine network in AML prognosis and immune evasion: A focus on the IL-1A-CCL3/4 axis as a novel therapeutic target

Free
Wang Shuqing, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 1456.
https://doi.org/10.1182/blood-2025-1456
Published: 2025
Journal Articles

Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Final update from the Phase 1/2 BRUIN study

Free
Michael Wang, Jonathon Cohen, Nirav Shah, Wojciech Jurczak, Pier Luigi Zinzani, Chan Cheah, Chaitra Ujjani, Youngil Koh, Won Seog Kim, Sunita Dwivedy Nasta, Ian Flinn, Benoit Tessoulin, Shuo Ma, Alvaro Alencar, David Lewis, Jennifer Woyach, Kami Maddocks, Krish Patel, Yucai Wang, Joanna Rhodes, Constantine Tam, John Seymour, Hirokazu Nagai, Julie Vose, Bita Fakhri, Marc Hoffmann, Francisco Hernandez-Ilizaliturri, Andrew Zelenetz, Anita Kumar, Talha Munir, Donald Tsai, Paolo Abada, Minna Balbas, Jian Li, Ying (denise) Wang, Lindsey Roeker, Toby Eyre
Journal: Blood
Blood (2025) 146 (Supplement 1): 665.
https://doi.org/10.1182/blood-2025-665
Published: 2025
Journal Articles

A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortium

Free
Mark Dowling, Vinay Vanguru, Stephen Boyle, Catelyn Cashion, Shafqat Inam, Thomas Buss, Anthony Jeffrey, Hamish Scott, Ross MacDonald, Jian Li, Nicole O'Leary, Adrian Minson, Christina Brown, Mary Ann Anderson, Gaurav Sutrave, Safia Belbachir, Jason Butler, Cameron Curley, Allison Barraclough, Constantine Tam, Andrea Henden, Emily Blyth, Phoebe Joy Ho, Simon Harrison, Michael Dickinson
Journal: Blood
Blood (2025) 146 (Supplement 1): 399.
https://doi.org/10.1182/blood-2025-399
Published: 2025
Journal Articles

Prognostic analysis of newly diagnosed systemic light-chain amyloidosis patients treated with daratumumab

Free
Yi Xu, Chengyang Xu, Ai Guan, Kaini Shen, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 2190.
https://doi.org/10.1182/blood-2025-2190
Published: 2025
Journal Articles

MC-MIL net: A multi-cascaded dual-stream multiple instance learning diagnostic framework for castleman disease.

Free
Yue Liu, Xue Shi, Rui Zhang, Jian Li, Ying Ma, Yuan Miao, Yin Dai, Hui-Han Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 7858.
https://doi.org/10.1182/blood-2025-7858
Published: 2025
Journal Articles

Pirtobrutinib in post-cbtki CLL/SLL: Final update from the Phase 1/2 BRUIN study with more than 5 years follow-up

Free
William Wierda, Jennifer Brown, Paolo Ghia, Lindsey Roeker, Krish Patel, Toby Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine Tam, John Seymour, Benoit Tessoulin, Nirav Shah, Chaitra Ujjani, Bita Fakhri, Catherine Coombs, Ian Flinn, Manish Patel, Sunita Dwivedy Nasta, Jonathon Cohen, Alvaro Alencar, Chan Cheah, Shuo Ma, Joanna Rhodes, Deepa Jagadeesh, Pier Luigi Zinzani, Anders Österborg, Koji Izutsu, Noriko Fukuhara, Donald Tsai, Paolo Abada, Minna Balbas, Jian Li, Ying (denise) Wang, Wojciech Jurczak, Jennifer Woyach
Journal: Blood
Blood (2025) 146 (Supplement 1): 2115.
https://doi.org/10.1182/blood-2025-2115
Published: 2025
Journal Articles

Relationship between changes in quality of life and social function and treatment response in patients with idiopathic multicentric castleman disease: A single-center observational longitudinal survey

Free
Jia Chen, Lu Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 8061.
https://doi.org/10.1182/blood-2025-8061
Published: 2025
Journal Articles

Real-world efficacy of inaticabtagene autoleucel in adult B-cell acute lymphoblastic leukemia patients with high-risk molecular alterations

Free
Xuan Zhou, JIN WANG, Hongsheng Zhou, Er-Lie Jiang, Chong Wang, Ying Wang, Jie Jin, Meng Lv, Xianmin Song, Xiaobing Huang, Jianmin Yang, Ruihua Mi, Lu Wang, Baohong Ping, Feng Zhu, Jing Huang, Zengjun Li, Xin Du, Jian Li, Aibin Liang, Yuhua Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 6865.
https://doi.org/10.1182/blood-2025-6865
Published: 2025
Journal Articles

Genetic analysis and clinical correlations in marginal zone lymphoma

Free
Wei Wang, Hao Cai, Yan Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 1768.
https://doi.org/10.1182/blood-2025-1768
Published: 2025
Journal Articles

Idiopathic multicentric castleman disease - tafro: A potentially curable disease?

Free
Lu Zhang, Jiaying Ge, Siyuan Li, Liangshun You, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 1230.
https://doi.org/10.1182/blood-2025-1230
Published: 2025
Journal Articles

Prognostic significance of pulmonary involvement in idiopathic multicentric castleman disease

Free
Yu-han Gao, Jia-min Zhou, Cong-Wei Jia, Siyuan Li, Yue Dang, Lu Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 1229.
https://doi.org/10.1182/blood-2025-1229
Published: 2025
Journal Articles

A novel conditioning regimen combining selinexor with melphalan  Improves Survival in Patients with multiple myeloma:a prospective study

Free
Liangliang Ma, Jingping Zhang, Xiaoqing Chen, Shanglun Yang, Youmei Fei, Qian Hu, Lejia Liu, Rongqiong Liao, Jian Li, Caigang Xu, Ting Niu, Yongqian Jia
Journal: Blood
Blood (2025) 146 (Supplement 1): 5837.
https://doi.org/10.1182/blood-2025-5837
Published: 2025
Journal Articles

Renal response of selinexor,  bortezomib, pomalidomide, and dexamethasone in newly diagnosed multiple myeloma patients with renal impairment: A phase 2, prospective, multicenter study

Free
Huixing Zhou, Long Chang, Jie Ma, Songying Zhao, Jingnan Sun, Sun Liping, Xiaoqi Qin, Hongmei Jing, Jingrong Wang, He-Bing Zhou, Xiaolei Chen, Hai Zhou, Zhenling Li, Wenrong Huang, Yi Ma, Guohong Su, Jun Luo, Guoxiang Zhang, Biyun Chen, Weiwei Tian, Guang-Yu Ma, Jihao Zhou, Wenming Chen, Hong-Hu Zhu, Jian Li, Wen Gao
Journal: Blood
Blood (2025) 146 (Supplement 1): 5830.
https://doi.org/10.1182/blood-2025-5830
Published: 2025
Journal Articles

Efficacy and safety of daratumumab plus carfilzomib-based induction/consolidation/maintenance therapy with autologous stem cell transplantation in transplant-eligible ultra high-risk newly diagnosed multiple myeloma: Preliminary results

Free
Jian Xu, Jian Li, Yongqiang Wei, Weijun Fu, Bingzong Li, Xiu Li Sun, Kaini Shen, Xiaolei Wei, Lu Li, Liying Zhang, He Xu, Yueying Mao, Dehu Li, Aoshuang Xu, Fei Zhao, Chunyan Sun
Journal: Blood
Blood (2025) 146 (Supplement 1): 5828.
https://doi.org/10.1182/blood-2025-5828
Published: 2025
Journal Articles

Updated survival outcomes of pomalidomide/bortezomib/dexamethasone in newly diagnosed multiple myeloma with renal impairment: A prospective, open-label, multicenter, phase 2 study

Free
Yuan Jian, Long Chang, Shi Minxia, Ying Sun, Xiao-Xia Chu, Hua Xue, Wenrong Huang, Xuliang Shen, Jie Ma, Guo-Rong Jia, Ya-Qing Feng, Zhen-Fang Xi, Yan-Hong Zhao, Yanping Ma, Jing Xiao, Guang-Yu Ma, Qing-Ming Wang, LI Bao, Yujun Dong, He-Bing Zhou, Chunyan Sun, Guo-Hong Su, Yan Yan, Sai-Yin Qimuge, Liping Su, Jingnan Sun, Weiwei Tian, Xiu Li Sun, Hongmei Jing, Da Gao, Hong-Hu Zhu, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2025) 146 (Supplement 1): 5818.
https://doi.org/10.1182/blood-2025-5818
Published: 2025
Journal Articles

Is 'severe’ imcd-IPL really severe?

Free
Siyuan Li, Yu-han Gao, Yue Dang, Jian Li, Lu Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1816.
https://doi.org/10.1182/blood-2025-1816
Published: 2025
Journal Articles

Efficacy and safety of orelabrutinib, obinutuzumab, and lenalidomide in previously untreated marginal zone lymphoma: Preliminary results from a prospective, single-arm, multicenter, Phase II study

Free
Wei Wang, Yueying Mao, Jing Ruan, Huacong Cai, Jin Ye, JunLi Chen, Liang Wang, Wenrong Huang, Yan Zhang, Jian Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 5383.
https://doi.org/10.1182/blood-2025-5383
Published: 2025